IceCure Advances Breast Cancer Cryoablation Study
Caesarea, Israel, August 20, 2026 IceCure Medical has announced an important clinical development for its minimally invasive ProSense® cryoablation...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Caesarea, Israel, August 20, 2026 IceCure Medical has announced an important clinical development for its minimally invasive ProSense® cryoablation...
Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...
Solana Beach, Calif., July 22, 2026 Artelo Biosciences announced the publication of a peer-reviewed review article in the British...
UNITED KINGDOM, June 17, 2026 Ananda Pharma Limited has announced that the first patient has been dosed in the...
